Carsten Nieder
Carsten Nieder,
Ilinca Popp,
Anca-Ligia Grosu
:
External Validation of an Extended Prognostic Assessment Model in Patients With Brain Metastases from Small‐cell Lung Cancer
Cancer Diagnosis & Prognosis (CDP) 2025 DOI
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Impact of Body Mass Index on Survival After Docetaxel Chemotherapy for Metastatic Castration‐resistant Prostate Cancer
Cancer Diagnosis & Prognosis (CDP) 2025 DOI
Carsten Nieder,
Ellinor Christin Haukland,
Luka Stanisavljevic,
Bård Mannsåker
:
Radiotherapy for Bone Metastases in Patients With Excellent Performance Status: Patterns of Care and Prognostic Factors for Survival
Anticancer Research 2025 DOI
Nicolaus Andratschke,
Astrid Heusel,
Nathalie L. Albert,
Filippo Alongi,
Brigitta G. Baumert,
Claus Belka
m.fl.:
ESTRO/EANO recommendation on reirradiation of glioblastoma
Radiotherapy and Oncology 2025 DOI
Mina Marie Solheim,
Carsten Nieder,
Ellinor Christin Haukland
:
Survival and Chemotherapy in the Last 30 Days as a Quality Indicator for Pancreatic Cancer
Anticancer Research 2025 DOI
Carsten Nieder,
Siv Gyda Aanes,
Luka Stanisavljevic,
Bård Mannsåker,
Ellinor Christin Haukland
:
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors
Carsten Nieder,
Siv Gyda Aanes,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Sex Differences in Presentation, Treatment, and Survival in Patients Receiving Palliative (Chemo)Radiotherapy for Non-Small Cell Lung Cancer
Jonas Willmann,
Panagiotis Balermpas,
Andreas Rimner,
Ane L Appelt,
Eliana Maria Vasquez Osorio,
Heidi S. Rønde
m.fl.:
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database
Radiotherapy and Oncology 2024 DOI
Carsten Nieder,
Ellinor Christin Haukland,
Luka Stanisavljevic,
Bård Mannsåker
:
Stereotactic radiotherapy for patients with bone metastases: a selected group with low rate of radiation treatment during the last month of life?
Carsten Nieder,
Stine Maria F. Jensen,
Solveig Nilsen,
Ellinor Christin Haukland
:
Palliative Radiation Treatment in Patients Managed With Advanced/Interventional Pain Therapy such as Pump-delivered Continuous Opioids
Carsten Nieder,
Siv Gyda Aanes,
Luka Stanisavljevic,
Bård Mannsåker,
Ellinor Christin Haukland
:
Return to work in younger patients with brain metastases who survived for 2 years or more
Carsten Nieder,
Luka Stanisavljevic,
Bård Mannsåker
:
Comprehensive Analysis of Blood Test Results Predicting Prognosis in Patients Undergoing Whole-brain Radiotherapy for Brain Metastases
Siv Gyda Aanes,
Siri Wiig,
Carsten Nieder,
Ellinor Christin Haukland
:
Implementing digital patient-reported outcomes in routine cancer care : barriers and facilitators
Carsten Nieder,
Luka Stanisavljevic,
Ellinor Christin Haukland
:
Factors Associated With Prescription of Systemic Therapy in Real-world Patients With Metastatic Renal Cell Cancer Managed in a Rural Region
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Survival after docetaxel for metastatic castration-resistant prostate cancer in a rural health care setting
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker
:
Return to Work After Breast Cancer Treatment: An Electronic Health Record-based Study in North Norway
Carsten Nieder,
Silje Kristine Johnsen,
Anette Merethe Winther,
Bård Mannsåker
:
Patient-reported symptoms before adjuvant locoregional radiotherapy for breast cancer: triple-negative histology impacts the symptom burden
Carsten Nieder,
Siv Gyda Aanes,
Luka Stanisavljevic,
Bård Mannsåker
:
Development of brain metastases in patients managed with non-curative thoracic radiotherapy for stage II/III non-small cell lung cancer
Jonas Willmann,
L. Appelt,
Panagiotis Balermpas,
G. Baumert,
Dirk de Ruysscher,
Morten Hoyer
m.fl.:
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
Ilinca Popp,
Nanna E. Hartong,
Carsten Nieder,
Anca-L. Grosu
:
PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
Carsten Nieder,
Kristian Steinsvik Imingen
:
Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival
Carsten Nieder,
Nicolaus H. Andratschke,
Anca L. Grosu
:
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Carsten Nieder,
Luka Stanisavljevic,
Bård Mannsåker,
Ellinor Christin Haukland
:
Independent Validation of a Unifying Prognostic Model for Intracranial and Extracranial Metastasis-directed Radiotherapy
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker,
Astrid Dalhaug
:
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
Carsten Nieder,
Luka Stanisavljevic,
Bård Mannsåker,
Ellinor Christin Haukland
:
Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
Carsten Nieder,
Bård Mannsåker,
Luka Stanisavljevic,
Ellinor Christin Haukland
:
Patterns of Care and Survival in Cancer Patients with Brain Metastases Receiving Immune Checkpoint Inhibitors
Carsten Nieder,
Siv Gyda Aanes,
Ellinor Christin Haukland
:
Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer
Carsten Nieder,
Astrid Dalhaug
:
Prognostic factors and independent validation of a risk stratification model in octogenarian patients irradiated for brain metastases
Carsten Nieder,
Luka Stanisavljevic,
Bård Mannsåker,
Ellinor Christin Haukland
:
Independent validation of a risk stratification model predicting survival in elderly patients irradiated for bone metastases
Carsten Nieder,
David McKenzie Grant
:
Considerations regarding carotid artery dose in radiotherapy of the cervical spine
Carsten Nieder,
Jonas Willmann,
Nicolaus H. Andratschke
:
Prospective randomized clinical studies involving reirradiation: update of a systematic review
Carsten Nieder,
Nicolaus H. Andratschke,
Anca L. Grosu
:
How we treat octogenarians with brain metastases
Carsten Nieder,
Bård Mannsåker,
Astrid Dalhaug
:
Percent of remaining life on palliative radiation treatment: solely a function of fractionation?
Carsten Nieder,
Nicolaus H. Andratschke,
Anca L. Grosu
:
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker,
Astrid Dalhaug
:
The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction
Carsten Nieder,
Ilinca Popp,
Mandy Hintz,
Anca Ligia Grosu
:
External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
Nicolaus Andratschke,
Jonas Willmann,
Ane L Appelt,
Najlaa Alyamani,
Panagiotis Balermpas,
Brigitta G Baumert
m.fl.:
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting
Carsten Nieder,
Luka Stanisavljevic
:
Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
Carsten Nieder,
Siv Gyda Aanes,
Ellinor Christin Haukland
:
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
Carsten Nieder,
Nicolaus H. Andratschke,
Anca L. Grosu
:
Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker
:
Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
Carsten Nieder,
Bård Mannsåker,
Rosalba Yobuta
:
Independent External Validation of the METSSS Model Predicting Survival after Palliative Radiotherapy
Carsten Nieder,
Astrid Dalhaug,
Bård Mannsåker
:
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
In Vivo 2022 DOI
Carsten Nieder,
Luka Stanisavljevic,
Siv Gyda Aanes,
Bård Mannsåker,
Ellinor Christin Haukland
:
30-day mortality in patients treated for brain metastases: extracranial causes dominate
Carsten Nieder,
Siv Gyda Aanes,
Ellinor Christin Haukland
:
Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?
Carsten Nieder,
Siv Gyda Aanes,
Ellinor Christin Haukland
:
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
Carsten Nieder,
Joakim Grønning Ressheim,
Ellinor Christin Haukland,
Bård Mannsåker
:
Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
Kjersti Øvrum Skipar,
Maren Synnøve Ørvik,
Christoph Evers,
Lise Balteskard,
Christian Ekanger,
Liv Ellen Giske
m.fl.:
Palliative radiotherapy in symptomatic pelvic soft tissue tumors (PallSoft)– protocol for a national, randomized, non-inferiority study
Siv Gyda Aanes,
Ellinor Christin Haukland,
Siri Wiig,
Carsten Nieder,
David Westfall Bates
:
Research protocol
Monitoring adverse events caused by systemic anticancer treatment – Safer Personalized Cancer Treatment digital follow-up - SPeCT
HNF1626-22
Ikke utgitt 2024 ARKIV
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →